In adenocarcinomas, its expression is primarily contributed by immune cells and has been closely associated with immune infiltration.35 In contrast, in squamous cell carcinomas, S100A8/A9 expression is predominantly derived from epithelial cells, particularly healthy squamous cells. Here, IGKV1D-22 is linked to squamous cell carcinoma.